SSA
LFST icon

Schonfeld Strategic Advisors’s Lifestance Health LFST Stock Holding History

Schonfeld Strategic Advisors’s Portfolio LFST Stock Details LFST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-52,020
Closed -$269K – 2405
2025
Q2 		$269K Buy
+52,020
New +$312K ﹤0.01% 1719
2025
Q1 		– Sell
-88,500
Closed -$652K – 2367
2024
Q4 		$652K Sell
88,500
-538,200
-86% -$3.86M ﹤0.01% 1297
2024
Q3 		$4.39M Buy
+626,700
New +$3.77M 0.03% 591
2023
Q3 		– Sell
-17,600
Closed -$161K – 2056
2023
Q2 		$161K Buy
+17,600
New +$146K ﹤0.01% 1624
2023
Q1 		– Sell
-225,114
Closed -$1.11M – 2384
2022
Q4 		$1.11M Sell
225,114
-76,461
-25% -$473K 0.01% 1088
2022
Q3 		$2M Buy
301,575
+151,575
+101% +$1.06M 0.02% 860
2022
Q2 		$834K Buy
+150,000
New +$1.15M 0.01% 1100
2021
Q3 		– Sell
-21,900
Closed -$611K – 2323
2021
Q2 		$611K Buy
+21,900
New +$579K 0.01% 1096

Other funds holding LFST

TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SP
Summit Partners Boston, Massachusetts $670M AUM 6.71% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Schonfeld Strategic Advisors's LFST Position: Q3 2025 in Review

Schonfeld Strategic Advisors sold out of Lifestance Health (LFST) in Q3 2025, closing a stake of 52,020 shares — an estimated $269K sold.

Schonfeld Strategic Advisors first reported a position in LFST in Q2 2021 and held it in 8 quarters. The position peaked at $4.39M in Q3 2024. 210 funds tracked by Wall St. Rank hold LFST as of Q3 2025.

  • Schonfeld Strategic Advisors reported no remaining Lifestance Health position as of Q3 2025 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 52,020 Lifestance Health shares in Q3 2025, an estimated $269K.
  • Schonfeld Strategic Advisors first reported a position in Lifestance Health in Q2 2021 and held it in 8 quarters.
  • Schonfeld Strategic Advisors's Lifestance Health position peaked at $4.39M in Q3 2024.
  • 210 funds tracked by Wall St. Rank held Lifestance Health as of Q3 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.